| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
62,382 |
55,771 |
$9.03M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
34,453 |
29,140 |
$4.66M |
| 71045 |
Radiologic examination, chest; single view |
20,984 |
17,659 |
$2.44M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,195 |
7,657 |
$1.37M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
24,409 |
19,998 |
$1.36M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,225 |
8,475 |
$1.12M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,695 |
729 |
$910K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
376 |
323 |
$674K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,869 |
1,567 |
$555K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
8,195 |
6,946 |
$537K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
4,713 |
4,357 |
$496K |
| 71046 |
Radiologic examination, chest; 2 views |
3,790 |
3,430 |
$300K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
58,548 |
47,644 |
$213K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,892 |
1,570 |
$191K |
| 80053 |
Comprehensive metabolic panel |
34,726 |
27,999 |
$178K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,258 |
10,589 |
$176K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,480 |
6,178 |
$116K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,364 |
2,222 |
$95K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
84 |
67 |
$92K |
| 30140 |
|
108 |
100 |
$83K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
67 |
62 |
$82K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,044 |
1,593 |
$64K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
315 |
148 |
$64K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,867 |
1,683 |
$59K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,708 |
4,813 |
$58K |
| 81001 |
|
34,849 |
29,992 |
$55K |
| 84484 |
|
5,661 |
4,584 |
$51K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13,494 |
11,222 |
$51K |
| 62323 |
|
49 |
41 |
$46K |
| 36415 |
Collection of venous blood by venipuncture |
21,794 |
17,074 |
$36K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
555 |
503 |
$36K |
| 87631 |
|
638 |
475 |
$32K |
| 81025 |
|
5,951 |
5,195 |
$26K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
14 |
12 |
$26K |
| 83880 |
|
1,396 |
1,167 |
$24K |
| 83735 |
|
7,102 |
5,597 |
$22K |
| 83690 |
|
7,389 |
6,252 |
$21K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
106 |
67 |
$19K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
560 |
471 |
$18K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
135 |
127 |
$16K |
| 11043 |
|
30 |
12 |
$15K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
616 |
577 |
$15K |
| 74018 |
|
133 |
128 |
$14K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
803 |
760 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
987 |
840 |
$10K |
| 82077 |
|
1,046 |
877 |
$10K |
| 99221 |
|
29 |
14 |
$10K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
135 |
115 |
$9K |
| 64493 |
|
19 |
12 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
982 |
659 |
$7K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
17 |
13 |
$7K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
22 |
12 |
$7K |
| 85730 |
|
2,736 |
2,174 |
$6K |
| 84703 |
|
1,294 |
1,136 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
54 |
40 |
$5K |
| 85610 |
|
2,912 |
2,315 |
$5K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
347 |
232 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
411 |
334 |
$4K |
| 64494 |
|
19 |
12 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
229 |
217 |
$4K |
| 11045 |
|
27 |
12 |
$3K |
| 83605 |
|
538 |
424 |
$3K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
22 |
12 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
15 |
13 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
641 |
538 |
$2K |
| 93017 |
|
23 |
13 |
$1K |
| 80076 |
|
240 |
196 |
$1K |
| 80143 |
|
110 |
100 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
241 |
212 |
$1K |
| 80179 |
|
94 |
87 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33 |
26 |
$913.92 |
| 85027 |
|
265 |
210 |
$858.09 |
| 87040 |
|
72 |
52 |
$621.40 |
| 82948 |
|
190 |
140 |
$607.15 |
| 73130 |
|
12 |
12 |
$595.40 |
| 87807 |
|
115 |
99 |
$565.67 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
45 |
36 |
$528.60 |
| 85379 |
|
72 |
61 |
$459.01 |
| 73630 |
|
26 |
24 |
$381.23 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
12 |
$306.77 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
12 |
$306.77 |
| 87081 |
|
120 |
96 |
$259.66 |
| 96367 |
|
22 |
13 |
$221.13 |
| 84443 |
Thyroid stimulating hormone (TSH) |
14 |
13 |
$201.60 |
| 84702 |
|
13 |
12 |
$116.97 |
| 82950 |
|
56 |
53 |
$106.66 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
23 |
14 |
$104.10 |
| 80306 |
|
18 |
15 |
$52.26 |
| 82150 |
|
30 |
25 |
$51.20 |
| 81003 |
|
82 |
53 |
$41.75 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,271 |
4,446 |
$39.15 |
| 86850 |
|
13 |
12 |
$15.63 |
| 80069 |
|
16 |
13 |
$10.40 |
| 86900 |
|
13 |
12 |
$8.97 |
| 86901 |
|
13 |
12 |
$8.97 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,764 |
5,691 |
$4.84 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
148 |
133 |
$4.66 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
452 |
372 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
45 |
38 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
292 |
237 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
184 |
152 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
19 |
12 |
$0.00 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
108 |
98 |
$0.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
71 |
64 |
$0.00 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
16 |
14 |
$0.00 |
| 90715 |
|
15 |
13 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,510 |
3,778 |
$0.00 |
| 36591 |
|
865 |
365 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,152 |
985 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
600 |
478 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
821 |
701 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
86 |
71 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
484 |
402 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
67 |
48 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
493 |
223 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
280 |
228 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
146 |
114 |
$0.00 |
| 88304 |
|
13 |
13 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
25 |
15 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
22 |
13 |
$0.00 |